HomeNDC LookupRxCUI directory › RxCUI 1246321

Formoterol fumarate 0.01 MG/ML Inhalation Solution [Perforomist] — RxCUI 1246321

RxNorm drug concept · Semantic branded drug
RxCUI 1246321 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1246321
Official nameFormoterol fumarate 0.01 MG/ML Inhalation Solution [Perforomist]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPerforomist 0.01 MG/ML Inhalation Solution; Perforomist 20 MCG in 2 ML Inhalation Solution; Perforomist 20 MCG per 2 ML Inhalation Solution
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,284 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Formoterol Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Formoterol helps keep your airways open over the course of the day. It relaxes the muscles around your airways so air can flow in and out more easily. It's a maintenance medication...
  • What exactly is formoterol supposed to do for my COPD?
  • No — formoterol is not a rescue inhaler and should not be used for sudden breathlessness or a COPD flare-up. For those moments, you need a separate short-acting inhaler (like albut...
  • Can I use it when I'm suddenly struggling to breathe?
📖 Read our full Formoterol Oral Inhalation guide →

🕸️ Concept Web — How Formoterol fumarate 0.01 MG/ML Inhalation Soluti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Formoterol fumarate 0.01 MG/ML Inhalation Solution [Perforomist] RxCUI 1246321

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Formoterol 25255
    • Formoterol fumarate 236216
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Perforomist 723732
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Formoterol Inhalation Solution 2108395
    • Formoterol fumarate Inhalation Solution 2648417
    • Formoterol Inhalant Product 1165648
    • Formoterol fumarate Inhalant Product 2661352
    • Formoterol Inhalation Solution [Perforomist] 2108397
    • Formoterol fumarate Inhalation Solution [Perforomist] 2654389
    • Perforomist Inhalant Product 1185816
    • Inhalation Solution 346161
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Formoterol fumarate 0.01 MG/ML Inhalation Solution SCD · 1246319
  • Formoterol fumarate 0.01 MG/ML SCDC · 1246318
  • Formoterol Inhalation Solution SCDF · 2108395
  • Formoterol fumarate Inhalation Solution SCDFP · 2648417
  • Formoterol Inhalant Product SCDG · 1165648
  • Formoterol fumarate Inhalant Product SCDGP · 2661352

Brand-Name Concepts

  • Formoterol fumarate 0.01 MG/ML [Perforomist] SBDC · 1246320
  • Formoterol Inhalation Solution [Perforomist] SBDF · 2108397
  • Formoterol fumarate Inhalation Solution [Perforomist] SBDFP · 2654389
  • Perforomist Inhalant Product SBDG · 1185816
  • Perforomist BN · 723732

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1246321 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49502-0605-30 30 POUCH in 1 CARTON (49502-605-30) / 1 VIAL in 1 POUCH / 2... Perforomist Viatris Specialty LLC 2007-10-01
49502-0605-61 60 POUCH in 1 CARTON (49502-605-61) / 1 VIAL in 1 POUCH (49... Perforomist Viatris Specialty LLC 2007-10-01
Observed labelers: Viatris Specialty LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$10.0821
Range $10.0486–$10.1156 · middle 50% $10.0654–$10.0989 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7606 Formoterol fumarate, inh 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.